Mikoplazma Enfeksiyonlarının Sinir Sistemi Bulguları ve Tedavisi
Özet
Mikoplazmalar, özellikle Mycoplasma pneumoniae, insanlarda merkezi sinir sistemi (SSS) enfeksiyonlarına yol açabilen ve genellikle solunum yolu belirtileriyle ilişkili olan küçük bakterilerdir. Nörolojik hasarlar, doğrudan doku hasarı, otoimmün mekanizmalar veya vasküler tutulum gibi çeşitli patogenezlerle gelişebilir ve ensefalit, menenjit gibi klinik tablolara neden olabilir. Tanı genellikle zorlu bir süreç olup, tedavi seçenekleri arasında sistemik antibiyotikler, immünoglobulinler ve kortikosteroidler yer alsa da, kesin bir fikir birliği henüz sağlanamamıştır.
Mycoplasmas, particularly Mycoplasma pneumoniae, are small bacteria that can cause central nervous system (CNS) infections in humans, often associated with respiratory symptoms. Neurological damage can develop through various pathogenic mechanisms, including direct tissue injury, autoimmune responses, or vascular involvement, leading to clinical conditions such as encephalitis and meningitis. Diagnosis is typically a challenging process, and while treatment options include systemic antibiotics, immunoglobulins, and corticosteroids, a definitive consensus has not yet been established.
Referanslar
Yesnick L. Central nervous system complications of primary atypical pneumonia. AMA Arch Intern Med. 1956;97:93–98.
Bitnun A, Richardson SE. Mycoplasmal infections. Singhi P, Griffin DE, Newton CR editors. Central Nervous System Infections in Childhood. 1st Edition. London; Mac Keith Press; 2014. p.278-288.
Walter ND, Grant GB, Bandy U, et al. Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness. J Infect Dis 2008;198:1365–74.
Bitnun A, Ford-Jones EL, Petric M, et al. Acute childhood encephalitis and Mycoplasma pneumoniae. Clin Infect Dis. 2001;32:1674–1784.
D’Alonzo R, Mencaroni E, Di Genova L, Laino D, Principi N, Esposito S. Pathogenesis and Treatment of Neurologic Diseases Associated With Mycoplasma pneumoniae Infection. Front. Microbiol. 2018;9:2751.
Kuwahara M, Samukawa M, Ikeda T, Morikawa M, Ueno R, Hamada Y, et al. Characterization of the neurological diseases associated with Mycoplasma pneumoniae infection and anti-glycolipid antibodies. J. Neurol. 2017;264:467–475.
Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J. Infect. Chemother. 2010;16:162–169.
Bitnun A, Richardson S. Mycoplasmal and Ureaplasmal infections. Scheld WM, Whitley RJ, Marra CM editors. Infections of The Central Nervous System. 4th Edition. Philadelphia; Wolters Kluwer Health; 2014. p. 420-433.
Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis. 1993;17 Suppl 1: S37–46.
Spuesens EB, Fraaij PL, Visser EG, Hoogenboezem T, Hop WC, van Adrichem LN, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10:e1001444.
Principi N, Esposito S. Appropriate use of fluoroquinolones in children. Int. J. Antimicrob. Agents 2015;45:341–346.
Bitnun A, Ford-Jones E, Blaser S, et al. Mycoplasma pneumoniae encephalitis. Sem Pediatr Infect Dis. 2003;14: 96–107.
Daxboeck F, Blacky A, Seidl R, et al. Diagnosis, treatment, and prognosis of Mycoplasma pneumoniae childhood encephalitis: systematic review of 58 cases. J Child Neurol 2004;19:865–71.
Tsiodras S, Kelesidis I, Kelesidis T, et al. Central nervous system manifestations of Mycoplasma pneumoniae infections. J Infect. 2005;51:343–54.
Tsiodras S, Kelesidis T, Kelesidis I, et al. Mycoplasma pneumoniae-associated myelitis: a comprehensive review. Europ J Neurol. 2006;13:112–24.
Hata A, Honda Y, Asada K, et al. Mycoplasma hominis meningitis in a neonate: case report and review. J Infect. 2008;57:338–43.
Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol. Rev. 2005;18:757–89.
